Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7: Changing Habits.

Nordström T, Clements MS, Adolfsson J, Grönberg H.

Eur Urol. 2013 Mar;63(3):427. doi: 10.1016/j.eururo.2012.12.005. Epub 2012 Dec 13. No abstract available.

PMID:
23265389
[PubMed - indexed for MEDLINE]
2.

Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.

Roobol MJ, Kranse R, Bangma CH, Otto SJ, van der Kwast TH, Bokhorst LP, de Koning HJ, Schröder FH.

Eur Urol. 2013 Oct;64(4):541-3. doi: 10.1016/j.eururo.2013.06.033. Epub 2013 Jun 26. No abstract available.

PMID:
23816273
[PubMed - indexed for MEDLINE]
3.

Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Belpomme D, Irigaray P.

J Natl Cancer Inst. 2010 Apr 7;102(7):506-7. doi: 10.1093/jnci/djq045. Epub 2010 Feb 26. No abstract available.

PMID:
20190186
[PubMed - indexed for MEDLINE]
Free Article
4.

Bad habits may be hard to break.

Vemana G, Andriole GL.

Eur Urol. 2013 Mar;63(3):426-7. doi: 10.1016/j.eururo.2012.11.044. Epub 2012 Nov 27. No abstract available.

PMID:
23206853
[PubMed - indexed for MEDLINE]
5.

Missing the mark on prostate-specific antigen screening.

Miller DC, Hollenbeck BK.

JAMA. 2011 Dec 28;306(24):2719-20. doi: 10.1001/jama.2011.1879. No abstract available.

PMID:
22203542
[PubMed - indexed for MEDLINE]
6.

Re: Monique J. Roobol, Fritz H. Schröder, Pim van Leeuwen, et al. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. Eur Urol 2010;58:475-81.

Connolly D, Hutton R, Keane PF.

Eur Urol. 2011 Mar;59(3):e9; author reply e10-1. doi: 10.1016/j.eururo.2010.11.035. Epub 2010 Dec 4. No abstract available.

PMID:
21145647
[PubMed - indexed for MEDLINE]
7.

A piece of my mind. Making the call.

Welch HG.

JAMA. 2011 Dec 28;306(24):2649-50. doi: 10.1001/jama.2011.1898. No abstract available.

PMID:
22203530
[PubMed - indexed for MEDLINE]
8.

Grading the new US Preventive Services Task Force prostate cancer screening recommendation.

Volk RJ, Wolf AM.

JAMA. 2011 Dec 28;306(24):2715-6. doi: 10.1001/jama.2011.1893. No abstract available.

PMID:
22203540
[PubMed - indexed for MEDLINE]
9.

Improving appropriateness of prostate-specific antigen screening.

Lippi G, Montagnana M, Guidi GC.

Arch Intern Med. 2007 Dec 10;167(22):2529-30. No abstract available.

PMID:
18071182
[PubMed - indexed for MEDLINE]
10.

The science and art of prostate cancer screening.

Yao SL, Lu-Yao GL.

J Natl Cancer Inst. 2011 Mar 16;103(6):450-1. doi: 10.1093/jnci/djr047. Epub 2011 Feb 24. No abstract available.

PMID:
21350220
[PubMed - indexed for MEDLINE]
Free Article
11.

Informed consent for prostate-specific antigen screening.

Wilkinson S, Chodak G.

Urology. 2003 Jan;61(1):2-4. No abstract available.

PMID:
12559252
[PubMed - indexed for MEDLINE]
12.

The devil and screening PSA.

Hopkins R.

J Ark Med Soc. 2012 Aug;109(2):30. No abstract available.

PMID:
22984706
[PubMed - indexed for MEDLINE]
13.

PSA screening: correlating noise with noise?

McGregor M.

CMAJ. 2002 Aug 20;167(4):340; author reply 340. No abstract available.

PMID:
12197684
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Informed consent for prostate-specific antigen-based screening.

Brawley OW.

Urology. 2003 Jan;61(1):10-2. No abstract available.

PMID:
12559255
[PubMed - indexed for MEDLINE]
15.

Informed consent for prostate-specific antigen screening.

Carter HB.

Urology. 2003 Jan;61(1):13-4. No abstract available.

PMID:
12559256
[PubMed - indexed for MEDLINE]
16.

Prostate cancer screening--time to abandon one-size-fits-all approach?

Kim J, Davis JW.

JAMA. 2011 Dec 28;306(24):2717-8. doi: 10.1001/jama.2011.1881. No abstract available.

PMID:
22203541
[PubMed - indexed for MEDLINE]
17.

Informed consent for prostate-specific antigen testing.

Gann PH.

Urology. 2003 Jan;61(1):5-6. No abstract available.

PMID:
12559253
[PubMed - indexed for MEDLINE]
18.

Recommendations on use of prostate-specific antigen for prostate cancer screening.

Garnick MB.

JAMA. 2012 Apr 4;307(13):1372; author reply 1372-4. doi: 10.1001/jama.2012.396. No abstract available.

PMID:
22474197
[PubMed - indexed for MEDLINE]
19.

Screening for prostate cancer: early detection or overdetection?

Vickers AJ, Roobol MJ, Lilja H.

Annu Rev Med. 2012;63:161-70. doi: 10.1146/annurev-med-050710-134421. Epub 2011 Nov 3. Review.

PMID:
22053739
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[About Psa-screening].

Hakama M, Auvinen A, Stenman UH, Tammela T.

Duodecim. 1996;112(14):1314-6. Finnish. No abstract available.

PMID:
10596108
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk